Emergence of resistance against direct acting antivirals in chronic HCV patients: A real-world study

Interferon/Ribavirin therapy has been replaced by Direct Acting Antivirals (DAAs) due to emergence of Resistance Associated Variants (RAVs) and decrease Sustain Virologic Response (SVR). Current study investigated treatment response of Sofosbuvir and Ribavirin in chronic HCV patients. Total 256 HCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Majid, Abdul, Khan, Sanaullah, Siraj, Sami, Haleem, Sumbal, ul Haq, Najib, Ullah, Riaz, Ali, Essam A., Mustafa, Adeela, Hussain, Hidayat, Sohaib, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072881/
https://www.ncbi.nlm.nih.gov/pubmed/35531150
http://dx.doi.org/10.1016/j.sjbs.2021.12.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072881/
https://www.ncbi.nlm.nih.gov/pubmed/35531150
http://dx.doi.org/10.1016/j.sjbs.2021.12.044

Ejemplares similares